Launching Spring 2027
The retinal literature, distilled
Four times a year, our editorial board picks the papers that matter in retina and practising experts explain why. A few minutes’ reading, with a link to the full article whenever you want to go deeper.
An open-access quarterly from Kugler Publications. Issue 1 appears in Spring 2027.
What is Retina Review
What was published, what matters, and why
Every quarter, more than a thousand papers on the retina are published: clinical trials, imaging studies, surgical technique, genetics, pharmacotherapy. Nobody can read them all.
Retina Review reads the literature for you. Our editorial board selects the papers of real clinical or scientific importance, and a specialist in the field writes a short commentary on each: what the study found, how strong the evidence is, and what it means for your patients.
Each issue is published as a PDF. Every commentary and abstract is also online, searchable and linked to the original article. Retina Review is open access, made possible by our sponsors.
For readers
Read at the depth you have time for
Each paper is presented in layers. Scan the highlights in minutes, or follow a paper all the way to the full article.
Highlights
The key point of each commentary in a sentence or two.
Expert commentary
What the paper found, how strong the evidence is, and what it means in the clinic.
Abstract
The original abstract with authors, journal, keywords and full citation.
Full article
A direct link to the paper on the publisher’s website. Access terms may apply.
Stay up to date
Get each new issue by email
Sign up and we will send you Issue 1 in Spring 2027, and every issue after that. We only email you when there is something worth reading, and you can unsubscribe at any time.
How it works
AI assists. Experts decide.
Software can summarise a paper in seconds. It has never examined a patient or performed a vitrectomy. So we use AI where it saves time, and people where judgement counts.
AI does the legwork
AI screens every newly published abstract, flags likely candidates and suggests a topic, so nothing important slips through.
Editors decide
Every paper in Retina Review is selected by our editorial board. The algorithm proposes; people choose.
Experts explain
Our commentators see patients and operate. They read a paper with the clinic and the operating theatre in mind, and they read between the lines.
-
Literature sweep
Each quarter, the newly published retinal literature is retrieved from PubMed.
-
AI-assisted screening
Every abstract is screened and likely candidates are flagged for the editorial board.
-
Editorial selection
The editorial board selects the papers of real clinical or scientific importance.
-
Expert commentary
A specialist in the field writes a short commentary on each paper.
-
Publication
The Kugler team edits and typesets the issue, online and as a PDF.
For contributors
Become one of our founding commentators
We are building an international pool of commentators: retinal specialists, surgeons, imaging experts and scientists with the knowledge and the ambition to take part.
- A focused format: one paper, one short commentary, with clear guidelines.
- Our editorial team takes care of language editing, layout and publication.
- Invitations match your expertise, and you decide how often you contribute.
- Co-authored commentaries are welcome.
- Your commentaries are published under your name and collected on your contributor profile.
Register your interest
For sponsors
Reach the retina community
Retina Review is open access for ophthalmologists and retinal specialists worldwide, from residents to senior consultants. Our sponsors make that possible, and their brand appears alongside the research these clinicians rely on.
-
Full-page advertisements
In every quarterly PDF issue.
-
Banner positions
On retina-review.com, alongside the commentaries and abstracts.
About
Published by Kugler Publications
Retina Review is published by Kugler Publications, the Amsterdam-based specialist publisher in ophthalmology. Kugler also produces International Glaucoma Review, the journal of the World Glaucoma Association, on which the Retina Review format builds.
Retina Review is run by an editorial board led by Managing Editor George Lambrou MD, whose career in ophthalmology spans glaucoma and retina, including roles at Bayer and Novartis. The members of the editorial board will be announced ahead of the first issue.
Managing Editor
George Lambrou MD
Athens, Greece
Editorial board to be announced